21013 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Albumins
Cell Transport Compositions and Uses Thereof
#302Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
#303INFANT FORMULA FOR OPTIMAL GROWTH, GASTROINTESTINAL PROTECTION AND IMMUNOLOGICAL PROTECTION OF INFANTS
#304Prophylactic and nutraceutical therapy
#305Site-specific labeling and targeted delivery of proteins for the treatment of cancer
#306Immunogenic composition and uses thereof
#307Potentiation of antibiotic treatment with a protein-lipid complex
#308Compositions and methods for reducing traumatic edema of the central nervous system
#309Nanoclusters compositions and methods
#310Active self-healing biomaterial system
#311Method for producing natural killer cells, natural killer cells produced thereby, and composition for treating cancers and infectious diseases containing the same
#312Method for the production of emulsion-based microparticles
#313METHODS AND COMPOSITIONS FOR IDENTIFICATION, ASSESSMENT AND TREATMENT OF CANCERS ASSOCIATED WITH HEDGEHOG SIGNALING
#314Compositions and methods of use for treating metabolic disorders
#315Internally functionalized graphene substrates
#316Inhibition of dynamin related protein 1 to promote cell death
#317Method of enhancing efficacy of blood transfusions
#318Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and a pharmaceutical composition obtained by the method
#319Arsenic compound solution and albumin nanoparticle and lyophilized preparation entrapping arsenic compound prepared using same
#320Nanoparticle-peptide compositions
#321Methods comprising dosing combinations for reducing undesired humoral immune responses
#322INFANT FORMULA WITH HIGH SN-2 PALMITATE AND OLIGOFRUCTOSE
#323Pharmaceutical composition for the treatment of type-1 diabetes
#324Intravascular delivery of nanoparticle compositions and uses thereof
#325Polyionic dendrimer and hydrogel comprising same
#326Thixotropic α-lactalbumin hydrogels, method for preparing same and uses thereof
#327Tolerogenic synthetic nanocarriers for inducing regulatory B cells
#328Methods for treatment of nephrotic syndrome and related conditions
#329Ingestible formulations for transient, noninvasive reduction of gastric volume
#330Cancer treatments
#331Food supplement having high immunological value, based on a protein matrix
#332Manufacturing and purification processes of Complex protein found in Fraction IV to make a separated Apo, Transferrin, and Alpha 1 Antitrypsin (A1AT) or a combined Transferrin/Apo/Human Albumin/A1AT and all new found proteins
#333Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin, and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin/Apo/Human Albumin/A1AT and all new found proteins
#334Use of liver growth factor (LGF) as a neural tissue regenerator
#335Method of use and preparation of HSA fusion protein composition for skincare
#336METHODS OF TREATING BLADDER CANCER
#337PHARMACEUTICAL COMBINED PREPARATION CONTAINING A THERAPEUTIC PROTEIN
#338MASS PRODUCTION OF READY-TO-USE SUSPENSIONS OF FIBRINOGEN-COATED ALBUMIN SPHERES FOR THE TREATMENT OF THROMBOCYTOPENIC PATIENTS
#339Minimizing intestinal dysfunction
#340Treatment with factor ix-albumin fusion protein
#341Antibacterial agent for treating infectious diseases of bacterial origin
#342Treatment with factor VII-albumin fusion protein
#343Multivalent breast cancer vaccine
#344METHODS OF TREATING BLADDER CANCER
#345Albumin Fusion Proteins
#346Method of deriving mature hepatocytes from human embryonic stem cells
#347Combinations and modes of administration of therapeutic agents and combination therapy
#348Water-soluble pharmaceutical composition comprising at least one therapeutically active substance having hydrophobic properties and at least one compound selected from among sialoglycosphingolipids, glycosphingolipids or a mixture of sialoglycosphingolipids and glycosphingolipids
#349SPARC and methods of use thereof
#350Use of 2 anti-SPARC antibodies to predict response to chemotherapy for pancreatic adenocarcinoma
#351PREVENTION OF INDWELLING DEVICE RELATED INFECTION: COMPOSITION AND METHODS
#352Factor IX polypeptides and methods of use thereof
#353Ferrimannitol-ovalbumin tablet composition
#354Method of treatment for neutropenia using stable formulations of recombinant human albumin-human granulocyte colony stimulating factor
#355Anti-tumor fibrillar human serum albumin methods and compositions
#356COMPOSITIONS AND METHODS FOR REDUCING EDEMA
#357Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
#358Method for treating amyloid disease
#359ORAL SUSTAINED RELEASE FORMULATION OF HUPERZINE A
#360Muteins of tear lipocalin and methods for obtaining the same
#361Fibrillar albumin for use in inhibiting cancer growth
#362SUPPRESSION OF CANCER METASTASIS
#363Compositions for mucosal delivery of agents
#364TOLEROGENIC SYNTHETIC NANOCARRIERS COUPLED TO CD1D-RESTRICTED ANTIGENS AND METHODS OF USE
#365CONTROLLED RELEASE OF IMMUNOSUPPRESSANTS FROM SYNTHETIC NANOCARRIERS
#366Tolerogenic synthetic nanocarriers for allergy therapy
#367ACTIVE SELF-HEALING BIOMATERIAL SYSTEM
#368NUTRITIONAL PRODUCTS
#369TOLEROGENIC SYNTHETIC NANOCARRIERS FOR REGULATING INNATE IMMUNE RESPONSES
#370Tolerogenic synthetic nanocarriers
#371Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responses
#372TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES
#373TOLEROGENIC SYNTHETIC NANOCARRIER COMPOSITIONS WITH TRANSPLANTABLE GRAFT ANTIGENS AND METHODS OF USE
#374Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
#375Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
#376Tolerogenic synthetic nanocarriers for inducing regulatory B cells
#377Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
#378Interleukin-11 Fusion Proteins
#379ALBUMIN FUSION PROTEINS
#380Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and pharmaceutical composition obtained by the method
#381FGFR1 extracellular domain combination therapies for lung cancer
#382AQUEOUS COMPOSITION COMPRISING GOLD NANOPARTICLES, SERUM ALBUMIN AND/OR COLLAGEN FOR LASER TISSUE WELDING
#383Synthetic synovial fluid compositions and methods for making the same
#384Combinations and modes of administration of therapeutic agents and combination therapy
#385Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins
#386Human Serum Albumin-Based Topical Ointment for Treatment of Acne, Psoriasis, Egfr-Induced Toxicity, Premature Skin Aging and Other Skin Conditions
#387Technology for the Preparation of Microparticles
#388Albumin fusion proteins
#389Albumin Fusion Proteins
#390Recombinant Human Albumin-Granulocyte Macrophage Colony Stimulating Factor Fusion Protein With Long-Lasting Biological Effects
#391Compositions and methods for biological remodeling with frozen particle compositions
#392Particulate composition and pharmaceutical composition containing the same
#393Particles for Inhalation Having Sustained Release Properties
#394Compositions and methods for biological remodeling with frozen particle compositions
#395POLYIONIC DENDRIMER AND HYDROGEL COMPRISING SAME
#396COMPOSITIONS, FORMULATIONS AND METHODS OF TREATING PREECLAMPSIA-TYPE DISORDERS OF PREGNANCY
#397Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
#398METHOD OF TREATING ECZEMA
#399IMMUNOGENIC COMPOSITION AND USES THEREOF
#400Targets for Growth Factor Signalling and Methods of Therapy
#401COMPOSITION AND PROCESS FOR SYNTHESIZING POLYMERIZED HUMAN SERUM ALBUMIN FOR APPLICATIONS IN TRANSFUSION MEDICINE
#402Resuscitation fluid
#403Resuscitation fluid
#404METHODS AND COMPOSITIONS FOR IDENTIFICATION, ASSESSMENT AND TREATMENT OF CANCERS ASSOCIATED WITH HEDGEHOG SIGNALING
#405Metabolic uncoupling therapy
#406SYNTHETIC GLYCOLIPID-CONTAINING LIPOSOME
#407Albumin Fusion Proteins
#408IMMUNE ENHANCING COMPOSITIONS AND METHODS OF USE THEREOF
#409TREATMENT OF DISEASES AND CONDITIONS MEDIATED BY INCREASED PHOSPHORYLATION
#410Treatment of diseases and conditions mediated by increased phosphorylation
#411Microfabricated nanopore device for sustained release of therapeutic agent
#412Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
#413Nanocluster compositions and methods
#414ALBUMIN FOR TREATING CANCER AND A PHARMACEUTICAL COMPOSITION COMPRISING THE COMBINATION OF AN ANTI-NEOPLASTIC AGENT AND ALBUMIN
#415Taxane- and taxoid-protein compositions
#416RAPID RECONSTITUTION FOR LYOPHILIZED-PHARMACEUTICAL SUSPENSIONS
#417Methods and apparatuses for endian conversion
#418Frozen compositions and methods for piercing a substrate
#419Process for obtaining high efficiency human albumin for use in detoxification therapy
#420Anti-tumor fibrillar human serum albumin methods and compositions
#421TUMORICIDAL, BACTERICIDAL, OR VIRICIDAL MACROPHAGE ACTIVATION
#422Compositions for mucosal delivery of agents
#423POLYMER ADAPTED TO RELEASE BIOACTIVE AGENTS IN VIVO, PHARMACEUTICAL COMPOSITION AND METHOD OF PREPARATION THEREOF
#424SELF-ASSEMBLING POLY(DIOL CITRATES)-PROTEIN HYDROGELS
#425PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRY EYE AND/OR CORNEAL AND CONJUNCTIVAL LESION
#426Treatment of conditions related to cecal ligation shock
#427Use of liver growth factor (LGF) as a neural tissue regenerator
#428Skincare composition comprising HSA fusion protein, preparation method and uses thereof
#429Antimicrobial Composition and Method for Use
#430Use of 2 anti-SPARC antibodies to predict response to melanoma chemotherapy
#431Treatment of conditions related to shock
#432PHARMACEUTICAL FORMULATION CONTAINING RECOMBINANT HUMAN SERUM ALBUMIN-INTERFERON ALPHA FUSION PROTEIN
#433Stable formulations of highly concentrated recombinant human albumin-human granulocyte colony stimulating factor
#434Albumin Fusion Proteins
#435PLASMIN-INHIBITORY THERAPIES
#436MEDICAMENT FOR TREATMENT OF TUMORS AND THE USE THEREOF
#437CROSS-LINKED HYDROGEL CONTAINING AN ACTIVE SUBSTANCE
#438METHOD FOR THE TREATMENT OF TYPE AND TYPE IV HYPERSENSITIVITY
#439Albumin Fusion Proteins
#440REPAIR OF RUPTURED MEMBRANE BY INJECTION OF NATURALLY OCCURRING PROTEIN IN AMNIOTIC FLUID SAC
#441Recombinant Human Albumin-Human Granulocyte Colony Stimulating Factor For The Prevention Of Neutropenia
#442Uses of pegylated albumin
#443Methods and compositions for treating recurrent cancer
#444MAMMALIAN REPRODUCTION
#445TARGETED OXYGEN DELIVERY VIA INTRAVENOUS OR INTRA-ARTERIAL INFUSION OF OXYGENATED POLYMERIZED HEMOGLOBIN SOLUTIONS
#446Micro-particles, blood-substitute and method for forming same
#447Solution and Method to Reduce, Treat and/or Prevent Oxidative Stress and Cell Activation
#448COMPOSITION FOR TREATING ISCHEMIC LIMB DISEASE COMPRISING STEM CELLS DERIVED FROM ADIPOSE TISSUE
#449Albumin Fusion Proteins
#450Systems, devices, and methods for making or administering frozen particles
#451Systems, devices, and methods for making or administering frozen particles
#452Tissue adhering compositions
#453Systems, devices, and methods for making or administering frozen particles
#454NUTRITIONAL PRODUCTS
#455Resuscitation Fluid
#456Systems, devices, and methods for making or administering frozen particles
#457Systems, devices and methods for making or administering frozen particles
#458Frozen compositions and methods for piercing a substrate
#459Prevention of indwelling device related infection: compositions and methods
#460Prevention of indwelling device related infection: compositions and methods
#461Interleukin-11 Fusion Proteins
#462Frozen compositions and methods for piercing a substrate
#463Extracellular matrix production from nanoscale substrate
#464Frozen compositions and methods for piercing a substrate
#465Solid fibrinogen preparation
#466Frozen compositions and array devices thereof
#467Compositions and methods for biological remodeling with frozen particle compositions
#468Frozen compositions and methods for piercing a substrate
#469Compositions and methods for biological remodeling with frozen particle compositions
#470Compositions and methods for biological remodeling with frozen particle compositions
#471Frozen piercing implements and methods for piercing a substrate
#472Frozen compositions and methods for piercing a substrate
#473Compositions and methods for biological remodeling with frozen particle compositions
#474Diagnosis and treatment of preeclampsia
#475Treatment of Hepatitis C Infection With Metalloporphyrins
#476Composition for maintaining gastrointestinal homeostasis
#477Methods for Detecting Overexpression of SPARC and Therapeutic and Diagnostic Methods Relating to Same
#478Recombinant human albumin-interleukin-11 fusion protein with long-lasting biological effects
#479S-Nitrosothiols Containing Composition for the Treatment of Fatty Liver Diseases, Obesity and Other Diseases Associated with the Metabolic Syndrome and the Use of Such Compositions
#480Albumin Fusion Proteins
#481Methods of Use of Eggshell Polypeptides
#482ALPHA-LACTALBUMIN COMPOSITION
#483COMPOSITIONS AND METHODS FOR INCREASING SERUM ANTIOXIDANT CONCENTRATIONS, DECREASING SERUM TRIGLYCERIDE LEVELS, INHIBITING INSULIN-RECEPTOR SIGNALING ACTIVITY, INCREASING SERUM GHRELIN LEVELS, AND DECREASING SERUM TNF-ALPHA LEVELS
#484BIOACTIVE SUBSTANCE-BLOOD PROTEIN CONJUGATE AND STABILIZATION OF A BIOACTIVE SUBSTANCE USING THE SAME
#485Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction
#486Use of alpha-lactalbumin for regulations of glycemia
#487LONG LASTING GLUCAGON-LIKE PEPTIDE 2 (GLP-2) FOR THE TREATMENT OF GASTROINTESTINAL DISEASES AND DISORDERS
#488Therapeutic Peptide Compositions And Methods Of Making And Using Same
#489Muteins of tear lipocalin and methods for obtaining the same
#490Albumin Fusion Proteins
#491Recombinant Production of Serum Albumin
#492Long Acting Human Interferon Analogs
#493Cell Transport Compositions and Uses Thereof
#494In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide
#495ENDOTHELIAL PREDECESSOR CELL SEEDED WOUND HEALING SCAFFOLD
#496NOVEL ANTITHROMBOTIC AGENT
#497Method for Producing Denatured Substance of Lactalbumin
#498Process for obtaining high efficiency human albumin for use in detoxification therapy
#499Methods of treating using hormone-albumin fusion proteins
#500Method for treating amyloid disease
#501Modified therapeutic peptides with extended half-lives in vivo
#502Resuscitation fluid
#503Use of therapeutic human albumin for treatment of alzheimer'S disease
#504Combinations and modes of administration of therapeutic agents and combination therapy
#505Technology for the Preparation of Microparticles
#506Protection of exendin-4 peptides through conjugation
#507Appetite Suppressant Composition and Method of Appetite Suppression
#508Composition for maintaining gastrointestinal homeostasis
#509Combinatorial improvement of bifunctional drug properties
#510Long acting human interferon analogs
#511Therapeutic Combination
#512Anti-hypertensive functional food products
#513Composition Comprising Silver Nanoparticles and the Use Thereof
#514METHODS AND COMPOSITIONS REGARDING POLYCHALCOGENIDE COMPOSITIONS
#515VACCINE COMPOSITION CONTAINING IRRADIATED OVALBUMIN FOR THE PREVENTION AND TREATMENT OF ALLERGIC DISEASE
#516PHARMACEUTICAL COMPOSITIONS AND METHODS FOR RESTORING BETA-CELL MASS AND FUNCTION
#517Process to produce fibrillar proteins
#518Resuscitation fluid
#519Method for treating allergic dermatitis
#520Interleukin-11 Fusion Proteins
#521Albumin Fusion Proteins
#522Albumin Fusion Proteins
#523Albumin Fusion Proteins
#524Albumin fusion proteins
#525Stabilizer molecule-depleted albumin solution
#526Albumin Fusion Proteins
#527STEROID CONJUGATES, PREPARATION THEREOF AND THE USE THEREOF
#528Lung volume reduction therapy using crosslinked biopolymers
#529Albumin Fusion Proteins
#530Particles for inhalation having sustained release properties
#531Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use
#532Ingestible formulations for transient, noninvasive reduction of gastric volume
#533Ply-GBS mutant lysins
#534Physiologically acceptable aqueous solutions and methods for their use
#535Active complex of α-lactalbumin (HAMLET) and cofactor
#536Albumin fusion proteins
#537Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction
#538Tissue adhering compositions
#539Composition and method for treating cancer
#540Methods and compositions for treating proliferative diseases
#541Lactalbumin for Inhibiting Angiogenesis
#542Method for modulating inflammatory responses by altering plasma lipid levels
#543METHODS FOR IMPROVED LIPID METABOLISM AND BASAL METABOLIC RATE WITH LACTOFERRIN
#544Recombinant human albumin-erythropoietin fusion proteins with long-lasting biological effects
#545DIAFILTRATION SYSTEM TO FRACTIONATE PROTEIN MIXTURES
#546Albumin fusion proteins
#547Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics
#548Albumin fusion proteins
#549Use of polypeptides in treating tissue injury
#550COMPOSITIONS AND METHODS FOR TREATING DIVERTICULAR DISEASE
#551Use of nitric oxide adducts
#552Pharmaceutical combined preparation containing a therapeutic protein
#553Use of Hamlet (Human Alpha-Lactalbumin Made Lethal to Tumour Cells) for Treating Viral Infections
#554COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS UTILIZING PROTEIN OR POLYSACCHARIDE CONTAINING ANTI-MICROTUBULE AGENTS
#555Method for the production of emulsion-based microparticles
#556Repair of ruptured membrane by injection of naturally occurring protein in amniotic fluid
#557Metabolic uncoupling therapy
#558Agent
#559Immunomodulatory methods using oligosaccharides
#560SPARC and methods of use thereof
#561Methods and compositions for treating proliferative diseases
#562Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
#563Microfabricated nanopore device for sustained release of therapeutic agent
#564Photoactivatable composition and uses thereof
#565Antiepileptogenic complex of albumin with docosahexaenoate
#566Particles for inhalation having sustained release properties
#567Method for treating amyloid disease
#568Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments
#569Process for producing albumin preparation
#570Storage and delivery vessel for two-part medicament
#571Neuroprotective complex for treatment of cerebral ischemia and injury
#572Method and ophthalmic formulation for eye protection or treatment
#573Combinations and modes of administration of therapeutic agents and combination therapy
#574Methods and formulations for delivery of pharmacologically active agents
#575Chimeric IL-10
#576Medical implants and fibrosis-inducing agents
#577Medical implants and fibrosis-inducing agents
#578Novel therapies and methods of screening for therapeutic compounds
#579Methods for modulating topical inflammatory response
#580Methods and compositions for preventing and treating radiation-induced skin reactions
#581Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders
#582Steroid conjugates, preparation thereof and the use thereof
#583Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction
#584Photoactivatable composition and uses thereof
#585Pharmaceutical compositions and methods for restoring β-cell mass and function
#586Method of providing hemostasis to a wound
#587Method and composition for resuscitation
#588Method and composition for resuscitation
#589Plasmin-inhibitory therapies
#590Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
#591Oxygenated albumin for use as blood and blood extender
#592Prekallikrein depleted plasma derived albumin fraction
#593Neuroprotective complex for treatment of cerebral ischemia and injury
#594Stable pharmaceutical compositions
#595Active complex of alpha-lactalbumin (hamlet) and cofactor
#596Biologic skin repair and enhancement
#597Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use
#598Lymph-like composition and method to prevent and treat central nervous system injuries
#599Composition and method to prevent and treat brain and spinal cord injuries
#600Stable lipid standards